Finally, Chopra et al. showed that treatment of irradiated recipient mice with a TNFR2 specific agonist protein successfully expanded radiation-resistant host Tregs in vivo, resulting in prolonged survival and reduced GvHD severity after transplantation. Here, TNFRSF1B is linked to graft versus host disease.